# JANUMET XR
> **NDA202270** · New Drug Application · Sponsor: MSD SUB MERCK · Approved 2012-02-02
## Drug
- **FDA Application Number:** NDA202270
- **Application type:** New Drug Application
- **Brand name:** JANUMET XR
- **Generic name:** SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
- **Active ingredients:** METFORMIN HYDROCHLORIDE; SITAGLIPTIN PHOSPHATE
- **Dosage form:** TABLET, EXTENDED RELEASE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MSD SUB MERCK
- **Manufacturer:** Merck Sharp & Dohme LLC
- **First approval:** 2012-02-02
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202270)
---
*MORVS · CC0 1.0*